{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T12:34:56Z","timestamp":1777638896536,"version":"3.51.4"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T00:00:00Z","timestamp":1556496000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100010904","name":"Major International Joint Research Programme","doi-asserted-by":"publisher","award":["81620108024"],"award-info":[{"award-number":["81620108024"]}],"id":[{"id":"10.13039\/501100010904","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81572679"],"award-info":[{"award-number":["81572679"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the National Natural Science foundation of","award":["81472882"],"award-info":[{"award-number":["81472882"]}]},{"name":"the National Natural Science foundation of","award":["81430075"],"award-info":[{"award-number":["81430075"]}]},{"name":"the National Natural Science foundation of","award":["81772917"],"award-info":[{"award-number":["81772917"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s12032-019-1270-4","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T07:08:11Z","timestamp":1556521691000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["N-Glycosylation in progression of skin cancer"],"prefix":"10.1007","volume":"36","author":[{"given":"Ling","family":"Tang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeye","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianglin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8187-636X","authenticated-orcid":false,"given":"Cong","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,29]]},"reference":[{"key":"1270_CR1","first-page":"120","volume":"810","author":"U Leiter","year":"2014","unstructured":"Leiter U, Eigentler T, Garbe C. Epidemiology of skin cancer. Adv Exp Med Biol. 2014;810:120\u201340.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"1270_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.det.2018.08.003","volume":"37","author":"EH Tracey","year":"2019","unstructured":"Tracey EH, Vij A. Updates in melanoma. Dermatol Clin. 2019;37(1):73\u201382. https:\/\/doi.org\/10.1016\/j.det.2018.08.003 .","journal-title":"Dermatol Clin"},{"key":"1270_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare5040082","author":"A Fahradyan","year":"2017","unstructured":"Fahradyan A, Howell AC, Wolfswinkel EM, Tsuha M, Sheth P, Wong AK. Updates on the management of non-melanoma skin cancer (NMSC). Healthcare. 2017. https:\/\/doi.org\/10.3390\/healthcare5040082 .","journal-title":"Healthcare"},{"issue":"6","key":"1270_CR4","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1542\/peds.109.6.1009","volume":"109","author":"AC Geller","year":"2002","unstructured":"Geller AC, Colditz G, Oliveria S, Emmons K, Jorgensen C, Aweh GN, et al. Use of sunscreen, sunburning rates, and tanning bed use among more than 10 000 US children and adolescents. Pediatrics. 2002;109(6):1009\u201314.","journal-title":"Pediatrics"},{"key":"1270_CR5","doi-asserted-by":"publisher","first-page":"12048","DOI":"10.1038\/ncomms12048","volume":"7","author":"HS Chahal","year":"2016","unstructured":"Chahal HS, Lin Y, Ransohoff KJ, Hinds DA, Wu W, Dai HJ, et al. Genome-wide association study identifies novel susceptibility loci for cutaneous squamous cell carcinoma. Nat Commun. 2016;7:12048. https:\/\/doi.org\/10.1038\/ncomms12048 .","journal-title":"Nat Commun"},{"issue":"5","key":"1270_CR6","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.jaad.2011.05.021","volume":"66","author":"KJ Buster","year":"2012","unstructured":"Buster KJ, You Z, Fouad M, Elmets C. Skin cancer risk perceptions: a comparison across ethnicity, age, education, gender, and income. J Am Acad Dermatol. 2012;66(5):771\u20139. https:\/\/doi.org\/10.1016\/j.jaad.2011.05.021 .","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"1270_CR7","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1158\/1541-7786.mcr-17-0292","volume":"16","author":"K Kinslechner","year":"2018","unstructured":"Kinslechner K, Schorghofer D, Schutz B, Vallianou M, Wingelhofer B, Mikulits W, et al. Malignant phenotypes in metastatic melanoma are governed by SR-BI and its association with glycosylation and STAT5 activation. Mol Cancer Res. 2018;16(1):135\u201346. https:\/\/doi.org\/10.1158\/1541-7786.mcr-17-0292 .","journal-title":"Mol Cancer Res"},{"issue":"7","key":"1270_CR8","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1083\/jcb.201501101","volume":"208","author":"MR Bond","year":"2015","unstructured":"Bond MR, Hanover JA. A little sugar goes a long way: the cell biology of O-GlcNAc. J Cell Biol. 2015;208(7):869\u201380. https:\/\/doi.org\/10.1083\/jcb.201501101 .","journal-title":"J Cell Biol"},{"key":"1270_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/srep00090","author":"GA Khoury","year":"2011","unstructured":"Khoury GA, Baliban RC, Floudas CA. Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database. Sci Rep. 2011. https:\/\/doi.org\/10.1038\/srep00090 .","journal-title":"Sci Rep"},{"issue":"4","key":"1270_CR10","doi-asserted-by":"publisher","first-page":"395","DOI":"10.4103\/ijdr.IJDR_632_16","volume":"28","author":"S Achalli","year":"2017","unstructured":"Achalli S, Madi M, Babu SG, Shetty SR, Kumari S, Bhat S. Sialic acid as a biomarker of oral potentially malignant disorders and oral cancer. Indian J Dent Res. 2017;28(4):395\u20139. https:\/\/doi.org\/10.4103\/ijdr.IJDR_632_16 .","journal-title":"Indian J Dent Res"},{"issue":"5512","key":"1270_CR11","doi-asserted-by":"publisher","first-page":"2364","DOI":"10.1126\/science.291.5512.2364","volume":"291","author":"A Helenius","year":"2001","unstructured":"Helenius A, Aebi M. Intracellular functions of N-linked glycans. Science. 2001;291(5512):2364\u20139.","journal-title":"Science"},{"issue":"9","key":"1270_CR12","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/j.bbagen.2012.01.013","volume":"1820","author":"DK Banerjee","year":"2012","unstructured":"Banerjee DK. N-glycans in cell survival and death: cross-talk between glycosyltransferases. Biochem Biophys Acta. 2012;1820(9):1338\u201346. https:\/\/doi.org\/10.1016\/j.bbagen.2012.01.013 .","journal-title":"Biochem Biophys Acta"},{"key":"1270_CR13","doi-asserted-by":"publisher","DOI":"10.6064\/2012\/489208","author":"JB Konopka","year":"2012","unstructured":"Konopka JB. N-acetylglucosamine (GlcNAc) functions in cell signaling. Scientifica. 2012. https:\/\/doi.org\/10.6064\/2012\/489208 .","journal-title":"Scientifica"},{"issue":"2","key":"1270_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1111\/cas.12049","volume":"104","author":"X Wang","year":"2013","unstructured":"Wang X, He H, Zhang H, Chen W, Ji Y, Tang Z, et al. Clinical and prognostic implications of beta1, 6-N-acetylglucosaminyltransferase V in patients with gastric cancer. Cancer Sci. 2013;104(2):185\u201393. https:\/\/doi.org\/10.1111\/cas.12049 .","journal-title":"Cancer Sci"},{"issue":"22","key":"1270_CR15","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1111\/febs.13419","volume":"282","author":"C Huang","year":"2015","unstructured":"Huang C, Huang M, Chen W, Zhu W, Meng H, Guo L, et al. N-acetylglucosaminyltransferase V modulates radiosensitivity and migration of small cell lung cancer through epithelial\u2013mesenchymal transition. FEBS J. 2015;282(22):4295\u2013306. https:\/\/doi.org\/10.1111\/febs.13419 .","journal-title":"FEBS J"},{"issue":"11","key":"1270_CR16","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1007\/s00345-014-1451-x","volume":"33","author":"Y Liu","year":"2015","unstructured":"Liu Y, Liu H, Liu W, Zhang W, An H, Xu J. Beta1,6-N-acetylglucosaminyltransferase V predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection. World J Urol. 2015;33(11):1791\u20139. https:\/\/doi.org\/10.1007\/s00345-014-1451-x .","journal-title":"World J Urol"},{"issue":"2","key":"1270_CR17","doi-asserted-by":"publisher","first-page":"323","DOI":"10.18388\/abp.2015_1050","volume":"62","author":"E Pochec","year":"2015","unstructured":"Pochec E, Rydlewska M, Przybylo M, Litynska A. Diverse expression of N-acetylglucosaminyltransferase V and complex-type beta1,6-branched N-glycans in uveal and cutaneous melanoma cells. Acta Biochim Pol. 2015;62(2):323\u20138. https:\/\/doi.org\/10.18388\/abp.2015_1050 .","journal-title":"Acta Biochim Pol"},{"issue":"17","key":"1270_CR18","doi-asserted-by":"crossref","first-page":"10235","DOI":"10.1016\/S0021-9258(18)34010-9","volume":"257","author":"S Narasimhan","year":"1982","unstructured":"Narasimhan S. Control of glycoprotein synthesis. UDP-GlcNAc:glycopeptide beta 4-N-acetylglucosaminyltransferase III, an enzyme in hen oviduct which adds GlcNAc in beta 1-4 linkage to the beta-linked mannose of the trimannosyl core of N-glycosyl oligosaccharides. J Biol Chem. 1982;257(17):10235\u201342.","journal-title":"J Biol Chem"},{"issue":"39","key":"1270_CR19","doi-asserted-by":"publisher","first-page":"16351","DOI":"10.1074\/jbc.M117.783936","volume":"292","author":"H Allam","year":"2017","unstructured":"Allam H, Johnson BP, Zhang M, Lu Z, Cannon MJ, Abbott KL. The glycosyltransferase GnT-III activates Notch signaling and drives stem cell expansion to promote the growth and invasion of ovarian cancer. J Biol Chem. 2017;292(39):16351\u20139. https:\/\/doi.org\/10.1074\/jbc.M117.783936 .","journal-title":"J Biol Chem"},{"issue":"3","key":"1270_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/BF00731325","volume":"12","author":"M Yoshimura","year":"1995","unstructured":"Yoshimura M, Ihara Y, Taniguchi N. Changes of beta-1,4-N-acetylglucosaminyltransferase III (GnT-III) in patients with leukaemia. Glycoconj J. 1995;12(3):234\u201340.","journal-title":"Glycoconj J"},{"issue":"19","key":"1270_CR21","doi-asserted-by":"publisher","first-page":"8754","DOI":"10.1073\/pnas.92.19.8754","volume":"92","author":"M Yoshimura","year":"1995","unstructured":"Yoshimura M, Nishikawa A, Ihara Y, Taniguchi S, Taniguchi N. Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci USA. 1995;92(19):8754\u20138.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"1270_CR22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1093\/glycob\/cwm022","volume":"17","author":"W Li","year":"2007","unstructured":"Li W, Takahashi M, Shibukawa Y, Yokoe S, Gu J, Miyoshi E, et al. Introduction of bisecting GlcNAc in N-glycans of adenylyl cyclase III enhances its activity. Glycobiology. 2007;17(6):655\u201362. https:\/\/doi.org\/10.1093\/glycob\/cwm022 .","journal-title":"Glycobiology"},{"issue":"48","key":"1270_CR23","doi-asserted-by":"publisher","first-page":"33036","DOI":"10.1074\/jbc.m804526200","volume":"283","author":"Y Kariya","year":"2008","unstructured":"Kariya Y, Kato R, Itoh S, Fukuda T, Shibukawa Y, Sanzen N, et al. N-glycosylation of laminin-332 regulates its biological functions. A novel function of the bisecting GlcNAc. J Biol Chem. 2008;283(48):33036\u201345. https:\/\/doi.org\/10.1074\/jbc.m804526200 .","journal-title":"J Biol Chem"},{"issue":"5","key":"1270_CR24","doi-asserted-by":"publisher","first-page":"3330","DOI":"10.1074\/jbc.M109.038836","volume":"285","author":"Y Kariya","year":"2010","unstructured":"Kariya Y, Kawamura C, Tabei T, Gu J. Bisecting GlcNAc residues on laminin-332 down-regulate galectin-3-dependent keratinocyte motility. J Biol Chem. 2010;285(5):3330\u201340. https:\/\/doi.org\/10.1074\/jbc.M109.038836 .","journal-title":"J Biol Chem"},{"issue":"11","key":"1270_CR25","doi-asserted-by":"publisher","first-page":"5708","DOI":"10.1074\/jbc.M115.712836","volume":"291","author":"J Lu","year":"2016","unstructured":"Lu J, Isaji T, Im S, Fukuda T, Kameyama A, Gu J. Expression of N-acetylglucosaminyltransferase III suppresses alpha2,3-sialylation, and its distinctive functions in cell migration are attributed to alpha2,6-sialylation levels. J Biol Chem. 2016;291(11):5708\u201320. https:\/\/doi.org\/10.1074\/jbc.M115.712836 .","journal-title":"J Biol Chem"},{"issue":"1","key":"1270_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/S0304-4165(99)00167-1","volume":"1473","author":"JW Dennis","year":"1999","unstructured":"Dennis JW, Granovsky M, Warren CE. Glycoprotein glycosylation and cancer progression. Biochem Biophys Acta. 1999;1473(1):21\u201334.","journal-title":"Biochem Biophys Acta"},{"issue":"9","key":"1270_CR27","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/j.bbagen.2007.05.006","volume":"1770","author":"M Przybylo","year":"2007","unstructured":"Przybylo M, Martuszewska D, Pochec E, Hoja-Lukowicz D, Litynska A. Identification of proteins bearing beta1-6 branched N-glycans in human melanoma cell lines from different progression stages by tandem mass spectrometry analysis. Biochem Biophys Acta. 2007;1770(9):1427\u201335. https:\/\/doi.org\/10.1016\/j.bbagen.2007.05.006 .","journal-title":"Biochem Biophys Acta"},{"key":"1270_CR28","first-page":"625","volume":"14","author":"M Przybylo","year":"2008","unstructured":"Przybylo M, Pochec E, Link-Lenczowski P, Litynska A. Beta1-6 branching of cell surface glycoproteins may contribute to uveal melanoma progression by up-regulating cell motility. Mol Vis. 2008;14:625\u201336.","journal-title":"Mol Vis"},{"issue":"1","key":"1270_CR29","doi-asserted-by":"publisher","first-page":"45","DOI":"10.3109\/07357907.2015.1102928","volume":"34","author":"E Pochec","year":"2016","unstructured":"Pochec E, Zabczynska M, Bubka M, Homa J, Litynska A. Beta1,6-branched complex-type N-glycans affect FAK signaling in metastatic melanoma cells. Cancer Invest. 2016;34(1):45\u201356. https:\/\/doi.org\/10.3109\/07357907.2015.1102928 .","journal-title":"Cancer Invest"},{"issue":"2\u20133","key":"1270_CR30","first-page":"287","volume":"1455","author":"N Taniguchi","year":"1999","unstructured":"Taniguchi N, Miyoshi E, Ko JH, Ikeda Y, Ihara Y. Implication of N-acetylglucosaminyltransferases III and V in cancer: gene regulation and signaling mechanism. Biochem Biophys Acta. 1999;1455(2\u20133):287\u2013300.","journal-title":"Biochem Biophys Acta"},{"key":"1270_CR31","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.carres.2012.10.009","volume":"364","author":"LM Tedaldi","year":"2012","unstructured":"Tedaldi LM, Pierce M, Wagner GK. Optimised chemical synthesis of 5-substituted UDP-sugars and their evaluation as glycosyltransferase inhibitors. Carbohydr Res. 2012;364:22\u20137. https:\/\/doi.org\/10.1016\/j.carres.2012.10.009 .","journal-title":"Carbohydr Res"},{"issue":"13","key":"1270_CR32","doi-asserted-by":"publisher","first-page":"3449","DOI":"10.1002\/chem.200501348","volume":"12","author":"S Hanashima","year":"2006","unstructured":"Hanashima S, Inamori K, Manabe S, Taniguchi N, Ito Y. Systematic synthesis of bisubstrate-type inhibitors of N-acetylglucosaminyltransferases. Chemistry. 2006;12(13):3449\u201362. https:\/\/doi.org\/10.1002\/chem.200501348 .","journal-title":"Chemistry"},{"issue":"10","key":"1270_CR33","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1158\/1541-7786.mcr-17-0120","volume":"15","author":"Z Hassani","year":"2017","unstructured":"Hassani Z, Saleh A, Turpault S, Khiati S, Morelle W, Vignon J, et al. Phostine PST3.1a targets MGAT5 and inhibits glioblastoma-initiating cell invasiveness and proliferation. Mol Cancer Res. 2017;15(10):1376\u201387. https:\/\/doi.org\/10.1158\/1541-7786.mcr-17-0120 .","journal-title":"Mol Cancer Res"},{"issue":"2","key":"1270_CR34","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.bbrc.2018.04.053","volume":"500","author":"J Zhang","year":"2018","unstructured":"Zhang J, Liu Y, Deng X, Chen L, Yang X, Yu C. ST6GAL1 negatively regulates monocyte transendothelial migration and atherosclerosis development. Biochem Biophys Res Commun. 2018;500(2):249\u201355. https:\/\/doi.org\/10.1016\/j.bbrc.2018.04.053 .","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"1270_CR35","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1074\/jbc.M117.808584","volume":"293","author":"A Chakraborty","year":"2018","unstructured":"Chakraborty A, Dorsett KA, Trummell HQ, Yang ES, Oliver PG, Bonner JA, et al. ST6Gal-I sialyltransferase promotes chemoresistance in pancreatic ductal adenocarcinoma by abrogating gemcitabine-mediated DNA damage. J Biol Chem. 2018;293(3):984\u201394. https:\/\/doi.org\/10.1074\/jbc.M117.808584 .","journal-title":"J Biol Chem"},{"issue":"3","key":"1270_CR36","doi-asserted-by":"publisher","first-page":"533","DOI":"10.18388\/abp.2015_1221","volume":"63","author":"E Kolasinska","year":"2016","unstructured":"Kolasinska E, Przybylo M, Janik M, Litynska A. Towards understanding the role of sialylation in melanoma progression. Acta Biochim Pol. 2016;63(3):533\u201341. https:\/\/doi.org\/10.18388\/abp.2015_1221 .","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"1270_CR37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1007\/s00262-005-0019-4","volume":"55","author":"P Laidler","year":"2006","unstructured":"Laidler P, Litynska A, Hoja-Lukowicz D, Labedz M, Przybylo M, Ciolczyk-Wierzbicka D, et al. Characterization of glycosylation and adherent properties of melanoma cell lines. Cancer Immunol Immunother. 2006;55(1):112\u20138. https:\/\/doi.org\/10.1007\/s00262-005-0019-4 .","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"1270_CR38","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.4081\/ejh.2013.e7","volume":"57","author":"SA Ferreira","year":"2013","unstructured":"Ferreira SA, Vasconcelos JL, Silva RC, Cavalcanti CL, Bezerra CL, Rego MJ, et al. Expression patterns of alpha2,3-sialyltransferase I and alpha2,6-sialyltransferase I in human cutaneous epithelial lesions. Eur J Histochem. 2013;57(1):e7. https:\/\/doi.org\/10.4081\/ejh.2013.e7 .","journal-title":"Eur J Histochem"},{"issue":"5","key":"1270_CR39","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1007\/s12038-013-9382-z","volume":"38","author":"A Ranjan","year":"2013","unstructured":"Ranjan A, Kalraiya RD. \u03b12,6 Sialylation associated with increased \u03b21,6-branched N-oligosaccharides influences cellular adhesion and invasion. J Biosci. 2013;38(5):867\u201376. https:\/\/doi.org\/10.1007\/s12038-013-9382-z .","journal-title":"J Biosci"},{"issue":"1","key":"1270_CR40","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/s13058-017-0904-8","volume":"19","author":"CF Tu","year":"2017","unstructured":"Tu CF, Wu MY, Lin YC, Kannagi R, Yang RB. FUT8 promotes breast cancer cell invasiveness by remodeling TGF-beta receptor core fucosylation. Breast Cancer Res. 2017;19(1):111. https:\/\/doi.org\/10.1186\/s13058-017-0904-8 .","journal-title":"Breast Cancer Res"},{"issue":"8","key":"1270_CR41","doi-asserted-by":"publisher","first-page":"3217","DOI":"10.1096\/fj.15-270710","volume":"29","author":"Y Wang","year":"2015","unstructured":"Wang Y, Fukuda T, Isaji T, Lu J, Im S, Hang Q, et al. Loss of alpha1,6-fucosyltransferase inhibits chemical-induced hepatocellular carcinoma and tumorigenesis by down-regulating several cell signaling pathways. FASEB J. 2015;29(8):3217\u201327. https:\/\/doi.org\/10.1096\/fj.15-270710 .","journal-title":"FASEB J"},{"issue":"5","key":"1270_CR42","doi-asserted-by":"publisher","first-page":"418","DOI":"10.2174\/157340607781745401","volume":"3","author":"D Ciolczyk-Wierzbicka","year":"2007","unstructured":"Ciolczyk-Wierzbicka D, Bodzioch M, Gil D, Zmudzinska D, Dembinska-Kiec A, Laidler P. Expression of fucosyltransferases contributes to melanoma invasive phenotype. Med Chem. 2007;3(5):418\u201324.","journal-title":"Med Chem"},{"issue":"406","key":"1270_CR43","doi-asserted-by":"publisher","first-page":"ra124","DOI":"10.1126\/scisignal.aac6479","volume":"8","author":"E Lau","year":"2015","unstructured":"Lau E, Feng Y, Claps G, Fukuda MN, Perlina A, Donn D, et al. The transcription factor ATF2 promotes melanoma metastasis by suppressing protein fucosylation. Sci Signal. 2015;8(406):ra124. https:\/\/doi.org\/10.1126\/scisignal.aac6479 .","journal-title":"Sci Signal"},{"issue":"6","key":"1270_CR44","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1016\/j.ccell.2017.05.007","volume":"31","author":"P Agrawal","year":"2017","unstructured":"Agrawal P, Fontanals-Cirera B, Sokolova E, Jacob S, Vaiana CA, Argibay D, et al. A systems biology approach identifies FUT8 as a driver of melanoma metastasis. Cancer Cell. 2017;31(6):804\u2013819.e7. https:\/\/doi.org\/10.1016\/j.ccell.2017.05.007 .","journal-title":"Cancer Cell."},{"issue":"11","key":"1270_CR45","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1016\/j.bmc.2017.02.036","volume":"25","author":"Y Manabe","year":"2017","unstructured":"Manabe Y, Kasahara S, Takakura Y, Yang X, Takamatsu S, Kamada Y, et al. Development of alpha1,6-fucosyltransferase inhibitors through the diversity-oriented syntheses of GDP-fucose mimics using the coupling between alkyne and sulfonyl azide. Bioorg Med Chem. 2017;25(11):2844\u201350. https:\/\/doi.org\/10.1016\/j.bmc.2017.02.036 .","journal-title":"Bioorg Med Chem"},{"issue":"7","key":"1270_CR46","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nrm3383","volume":"13","author":"KW Moremen","year":"2012","unstructured":"Moremen KW, Tiemeyer M, Nairn AV. Vertebrate protein glycosylation: diversity, synthesis and function. Nat Rev Mol Cell Biol. 2012;13(7):448\u201362. https:\/\/doi.org\/10.1038\/nrm3383 .","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1270_CR47","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/S0304-4165(99)00165-8","volume":"1473","author":"R Apweiler","year":"1999","unstructured":"Apweiler R, Hermjakob H, Sharon N. On the frequency of protein glycosylation, as deduced from analysis of the SWISS-PROT database. Biochem Biophys Acta. 1999;1473(1):4\u20138.","journal-title":"Biochem Biophys Acta"},{"key":"1270_CR48","doi-asserted-by":"publisher","first-page":"490531","DOI":"10.1155\/2015\/490531","volume":"2015","author":"A Kirwan","year":"2015","unstructured":"Kirwan A, Utratna M, O\u2019Dwyer ME, Joshi L, Kilcoyne M. Glycosylation-based serum biomarkers for cancer diagnostics and prognostics. Biomed Res Int. 2015;2015:490531. https:\/\/doi.org\/10.1155\/2015\/490531 .","journal-title":"Biomed Res Int"},{"issue":"12","key":"1270_CR49","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.1016\/j.clinthera.2017.11.002","volume":"39","author":"F Pandolfi","year":"2017","unstructured":"Pandolfi F, Franza L, Altamura S, Mandolini C, Cianci R, Ansari A, et al. Integrins: integrating the biology and therapy of cell\u2013cell interactions. Clin Ther. 2017;39(12):2420\u201336. https:\/\/doi.org\/10.1016\/j.clinthera.2017.11.002 .","journal-title":"Clin Ther"},{"issue":"2","key":"1270_CR50","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ijc.2910440226","volume":"44","author":"OK Oz","year":"1989","unstructured":"Oz OK, Campbell A, Tao TW. Reduced cell adhesion to fibronectin and laminin is associated with altered glycosylation of beta 1 integrins in a weakly metastatic glycosylation mutant. Int J Cancer. 1989;44(2):343\u20137.","journal-title":"Int J Cancer"},{"issue":"1","key":"1270_CR51","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1002\/ijc.2910530118","volume":"53","author":"T Kawano","year":"1993","unstructured":"Kawano T, Takasaki S, Tao TW, Kobata A. Altered glycosylation of beta 1 integrins associated with reduced adhesiveness to fibronectin and laminin. Int J Cancer. 1993;53(1):91\u20136.","journal-title":"Int J Cancer"},{"issue":"1\u20133","key":"1270_CR52","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.bbamcr.2003.10.004","volume":"1643","author":"E Pochec","year":"2003","unstructured":"Pochec E, Litynska A, Amoresano A, Casbarra A. Glycosylation profile of integrin alpha 3 beta 1 changes with melanoma progression. Biochem Biophys Acta. 2003;1643(1\u20133):113\u201323.","journal-title":"Biochem Biophys Acta"},{"issue":"19","key":"1270_CR53","doi-asserted-by":"publisher","first-page":"19747","DOI":"10.1074\/jbc.M311627200","volume":"279","author":"T Isaji","year":"2004","unstructured":"Isaji T, Gu J, Nishiuchi R, Zhao Y, Takahashi M, Miyoshi E, et al. Introduction of bisecting GlcNAc into integrin alpha5beta1 reduces ligand binding and down-regulates cell adhesion and cell migration. J Biol Chem. 2004;279(19):19747\u201354. https:\/\/doi.org\/10.1074\/jbc.M311627200 .","journal-title":"J Biol Chem"},{"issue":"3","key":"1270_CR54","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1023\/A:1006304806799","volume":"18","author":"JP Johnson","year":"1999","unstructured":"Johnson JP. Cell adhesion molecules in the development and progression of malignant melanoma. Cancer Metastasis Rev. 1999;18(3):345\u201357.","journal-title":"Cancer Metastasis Rev"},{"issue":"5","key":"1270_CR55","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.biochi.2005.10.012","volume":"88","author":"A Litynska","year":"2006","unstructured":"Litynska A, Przybylo M, Pochec E, Kremser E, Hoja-Lukowicz D, Sulowska U. Does glycosylation of melanoma cells influence their interactions with fibronectin? Biochimie. 2006;88(5):527\u201334. https:\/\/doi.org\/10.1016\/j.biochi.2005.10.012 .","journal-title":"Biochimie"},{"issue":"8","key":"1270_CR56","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1002\/ijc.22062","volume":"119","author":"S Riethdorf","year":"2006","unstructured":"Riethdorf S, Reimers N, Assmann V, Kornfeld JW, Terracciano L, Sauter G, et al. High incidence of EMMPRIN expression in human tumors. Int J Cancer. 2006;119(8):1800\u201310. https:\/\/doi.org\/10.1002\/ijc.22062 .","journal-title":"Int J Cancer"},{"issue":"3","key":"1270_CR57","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jdermsci.2009.12.008","volume":"57","author":"T Kanekura","year":"2010","unstructured":"Kanekura T, Chen X. CD147\/basigin promotes progression of malignant melanoma and other cancers. J Dermatol Sci. 2010;57(3):149\u201354. https:\/\/doi.org\/10.1016\/j.jdermsci.2009.12.008 .","journal-title":"J Dermatol Sci"},{"issue":"1","key":"1270_CR58","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1111\/j.1346-8138.2011.01304.x","volume":"39","author":"R Nishibaba","year":"2012","unstructured":"Nishibaba R, Higashi Y, Su J, Furukawa T, Kawai K, Kanekura T. CD147-targeting siRNA inhibits cell\u2013matrix adhesion of human malignant melanoma cells by phosphorylating focal adhesion kinase. J Dermatol. 2012;39(1):63\u20137. https:\/\/doi.org\/10.1111\/j.1346-8138.2011.01304.x .","journal-title":"J Dermatol"},{"issue":"3","key":"1270_CR59","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.jdermsci.2010.03.022","volume":"58","author":"J Li","year":"2010","unstructured":"Li J, Peng L, Wu L, Kuang Y, Su J, Yi M, et al. Depletion of CD147 sensitizes human malignant melanoma cells to hydrogen peroxide-induced oxidative stress. J Dermatol Sci. 2010;58(3):204\u201310. https:\/\/doi.org\/10.1016\/j.jdermsci.2010.03.022 .","journal-title":"J Dermatol Sci"},{"issue":"1","key":"1270_CR60","doi-asserted-by":"publisher","first-page":"163","DOI":"10.2174\/15665240113136660077","volume":"14","author":"W Zeng","year":"2014","unstructured":"Zeng W, Su J, Wu L, Yang D, Long T, Li D, et al. CD147 promotes melanoma progression through hypoxia-induced MMP2 activation. Curr Mol Med. 2014;14(1):163\u201373.","journal-title":"Curr Mol Med"},{"issue":"12","key":"1270_CR61","first-page":"7091","volume":"34","author":"M Hatanaka","year":"2014","unstructured":"Hatanaka M, Higashi Y, Fukushige T, Baba N, Kawai K, Hashiguchi T, et al. Cleaved CD147 shed from the surface of malignant melanoma cells activates MMP2 produced by fibroblasts. Anticancer Res. 2014;34(12):7091\u20136.","journal-title":"Anticancer Res"},{"issue":"10","key":"1270_CR62","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.2174\/1566524014666141202144601","volume":"14","author":"Z Luo","year":"2014","unstructured":"Luo Z, Zeng W, Tang W, Long T, Zhang J, Xie X, et al. CD147 interacts with NDUFS6 in regulating mitochondrial complex I activity and the mitochondrial apoptotic pathway in human malignant melanoma cells. Curr Mol Med. 2014;14(10):1252\u201364.","journal-title":"Curr Mol Med"},{"issue":"4","key":"1270_CR63","doi-asserted-by":"publisher","first-page":"6356","DOI":"10.3390\/ijms15046356","volume":"15","author":"Y Bai","year":"2014","unstructured":"Bai Y, Huang W, Ma LT, Jiang JL, Chen ZN. Importance of N-glycosylation on CD147 for its biological functions. Int J Mol Sci. 2014;15(4):6356\u201377. https:\/\/doi.org\/10.3390\/ijms15046356 .","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1270_CR64","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1042\/bj20120343","volume":"449","author":"W Huang","year":"2013","unstructured":"Huang W, Luo WJ, Zhu P, Tang J, Yu XL, Cui HY, et al. Modulation of CD147-induced matrix metalloproteinase activity: role of CD147 N-glycosylation. Biochem J. 2013;449(2):437\u201348. https:\/\/doi.org\/10.1042\/bj20120343 .","journal-title":"Biochem J"},{"key":"1270_CR65","doi-asserted-by":"publisher","first-page":"35210","DOI":"10.1038\/srep35210","volume":"6","author":"JH Li","year":"2016","unstructured":"Li JH, Huang W, Lin P, Wu B, Fu ZG, Shen HM, et al. N-linked glycosylation at Asn152 on CD147 affects protein folding and stability: promoting tumour metastasis in hepatocellular carcinoma. Sci Rep. 2016;6:35210. https:\/\/doi.org\/10.1038\/srep35210 .","journal-title":"Sci Rep"},{"issue":"6","key":"1270_CR66","doi-asserted-by":"publisher","first-page":"4035","DOI":"10.3892\/mmr.2017.6523","volume":"15","author":"S Liu","year":"2017","unstructured":"Liu S, Li S, Zhang Y, Wang Y, Zhu Y, Wang B, et al. Purification of a polyclonal antibody against CD147 for ELISA using antigenimmunoaffinity chromatography. Mol Med Rep. 2017;15(6):4035\u201340. https:\/\/doi.org\/10.3892\/mmr.2017.6523 .","journal-title":"Mol Med Rep"},{"issue":"1","key":"1270_CR67","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1002\/path.5054","volume":"245","author":"J Cui","year":"2018","unstructured":"Cui J, Huang W, Wu B, Jin J, Jing L, Shi WP, et al. N-glycosylation by N-acetylglucosaminyltransferase V enhances the interaction of CD147\/basigin with integrin beta1 and promotes HCC metastasis. J Pathol. 2018;245(1):41\u201352. https:\/\/doi.org\/10.1002\/path.5054 .","journal-title":"J Pathol"},{"key":"1270_CR68","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/jcb.26713","volume":"56","author":"NY Ru","year":"2018","unstructured":"Ru NY, Cui LB, Jiao B, Zhang L, Jiang S, Yu ZB. Glycosylated CD147 reduces myocardial collagen cross-linking in cardiac hypertrophy. J Cell Biochem. 2018;56:7. https:\/\/doi.org\/10.1002\/jcb.26713 .","journal-title":"J Cell Biochem"},{"issue":"26","key":"1270_CR69","doi-asserted-by":"publisher","first-page":"18327","DOI":"10.18632\/oncotarget.24192","volume":"9","author":"C Liu","year":"2018","unstructured":"Liu C, Qiu H, Lin D, Wang Z, Shi N, Tan Z, et al. c-Jun-dependent beta3GnT8 promotes tumorigenesis and metastasis of hepatocellular carcinoma by inducing CD147 glycosylation and altering N-glycan patterns. Oncotarget. 2018;9(26):18327\u201340. https:\/\/doi.org\/10.18632\/oncotarget.24192 .","journal-title":"Oncotarget."},{"issue":"10 Pt A","key":"1270_CR70","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1016\/j.bbadis.2017.02.027","volume":"1863","author":"C Herraiz","year":"2017","unstructured":"Herraiz C, Garcia-Borron JC, Jimenez-Cervantes C, Olivares C. MC1R signaling. Intracellular partners and pathophysiological implications. Biochimica Biophys Acta Mol Basis Dis. 2017;1863(10 Pt A):2448\u201361. https:\/\/doi.org\/10.1016\/j.bbadis.2017.02.027 .","journal-title":"Biochimica Biophys Acta Mol Basis Dis"},{"key":"1270_CR71","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.abb.2014.07.003","volume":"563","author":"CI Rodriguez","year":"2014","unstructured":"Rodriguez CI, Setaluri V. Cyclic AMP (cAMP) signaling in melanocytes and melanoma. Arch Biochem Biophys. 2014;563:22\u20137. https:\/\/doi.org\/10.1016\/j.abb.2014.07.003 .","journal-title":"Arch Biochem Biophys"},{"issue":"3","key":"1270_CR72","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/ijc.29018","volume":"136","author":"E Pasquali","year":"2015","unstructured":"Pasquali E, Garcia-Borron JC, Fargnoli MC, Gandini S, Maisonneuve P, Bagnardi V, et al. MC1R variants increased the risk of sporadic cutaneous melanoma in darker-pigmented Caucasians: a pooled-analysis from the M-SKIP project. Int J Cancer. 2015;136(3):618\u201331. https:\/\/doi.org\/10.1002\/ijc.29018 .","journal-title":"Int J Cancer"},{"issue":"4","key":"1270_CR73","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/sj.bjc.6600441","volume":"87","author":"F Salazar-Onfray","year":"2002","unstructured":"Salazar-Onfray F, Lopez M, Lundqvist A, Aguirre A, Escobar A, Serrano A, et al. Tissue distribution and differential expression of melanocortin 1 receptor, a malignant melanoma marker. Br J Cancer. 2002;87(4):414\u201322. https:\/\/doi.org\/10.1038\/sj.bjc.6600441 .","journal-title":"Br J Cancer"},{"issue":"3","key":"1270_CR74","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/j.1755-148X.2011.00848.x","volume":"24","author":"C Herraiz","year":"2011","unstructured":"Herraiz C, Sanchez-Laorden BL, Jimenez-Cervantes C, Garcia-Borron JC. N-glycosylation of the human melanocortin 1 receptor: occupancy of glycosylation sequons and functional role. Pigment Cell Melanoma Res. 2011;24(3):479\u201389. https:\/\/doi.org\/10.1111\/j.1755-148X.2011.00848.x .","journal-title":"Pigment Cell Melanoma Res"},{"issue":"5","key":"1270_CR75","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1159\/000484109","volume":"43","author":"QX Qu","year":"2017","unstructured":"Qu QX, Xie F, Huang Q, Zhang XG. Membranous and cytoplasmic expression of PD-L1 in ovarian cancer cells. Cell Physiol Biochem. 2017;43(5):1893\u2013906. https:\/\/doi.org\/10.1159\/000484109 .","journal-title":"Cell Physiol Biochem"},{"key":"1270_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.304","author":"K Kondo","year":"2017","unstructured":"Kondo K, Shaim H, Thompson PA, Burger JA, Keating M, Estrov Z, et al. Ibrutinib modulates the immunosuppressive CLL microenvironment through STAT3-mediated suppression of regulatory B-cell function and inhibition of the PD-1\/PD-L1 pathway. Leukemia. 2017. https:\/\/doi.org\/10.1038\/leu.2017.304 .","journal-title":"Leukemia"},{"key":"1270_CR77","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2174\/1381612823666171004120152","volume":"56","author":"Q Geng","year":"2017","unstructured":"Geng Q, Jiao P, Jin P, Su G, Dong J, Yan B. PD-1\/PD-L1 inhibitors for immuno-oncology: from antibodies to small molecules. Curr Pharm Des. 2017;56:67. https:\/\/doi.org\/10.2174\/1381612823666171004120152 .","journal-title":"Curr Pharm Des."},{"issue":"23","key":"1270_CR78","doi-asserted-by":"publisher","first-page":"6964","DOI":"10.1158\/0008-5472.can-16-0258","volume":"76","author":"CA Clark","year":"2016","unstructured":"Clark CA, Gupta HB, Sareddy G, Pandeswara S, Lao S, Yuan B, et al. Tumor-intrinsic PD-L1 signals regulate cell growth, pathogenesis, and autophagy in ovarian cancer and melanoma. Can Res. 2016;76(23):6964\u201374. https:\/\/doi.org\/10.1158\/0008-5472.can-16-0258 .","journal-title":"Can Res"},{"issue":"2","key":"1270_CR79","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1053\/j.seminoncol.2017.06.002","volume":"44","author":"P Fessas","year":"2017","unstructured":"Fessas P, Lee H, Ikemizu S, Janowitz T. A molecular and preclinical comparison of the PD-1-targeted T-cell checkpoint inhibitors nivolumab and pembrolizumab. Semin Oncol. 2017;44(2):136\u201340. https:\/\/doi.org\/10.1053\/j.seminoncol.2017.06.002 .","journal-title":"Semin Oncol"},{"key":"1270_CR80","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx642","author":"MH Pollack","year":"2017","unstructured":"Pollack MH, Betof A, Dearden H, Rapazzo K, Valentine I, Brohl AS, et al. Safety of resuming anti-PD-1 in patients with immune-related adverse events (irAEs) during combined anti-CTLA-4 and anti-PD1 in metastatic melanoma. Ann Oncol. 2017. https:\/\/doi.org\/10.1093\/annonc\/mdx642 .","journal-title":"Ann Oncol"},{"key":"1270_CR81","doi-asserted-by":"publisher","first-page":"12632","DOI":"10.1038\/ncomms12632","volume":"7","author":"CW Li","year":"2016","unstructured":"Li CW, Lim SO, Xia W, Lee HH, Chan LC, Kuo CW, et al. Glycosylation and stabilization of programmed death ligand-1 suppresses T-cell activity. Nat Commun. 2016;7:12632. https:\/\/doi.org\/10.1038\/ncomms12632 .","journal-title":"Nat Commun"},{"key":"1270_CR82","doi-asserted-by":"publisher","first-page":"14369","DOI":"10.1038\/ncomms14369","volume":"8","author":"S Tan","year":"2017","unstructured":"Tan S, Zhang H, Chai Y, Song H, Tong Z, Wang Q, et al. An unexpected N-terminal loop in PD-1 dominates binding by nivolumab. Nat Commun. 2017;8:14369. https:\/\/doi.org\/10.1038\/ncomms14369 .","journal-title":"Nat Commun"},{"key":"1270_CR83","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.cellsig.2018.07.010","volume":"51","author":"K Kyriakopoulou","year":"2018","unstructured":"Kyriakopoulou K, Kefali E, Piperigkou Z, Bassiony H, Karamanos NK. Advances in targeting epidermal growth factor receptor signaling pathway in mammary cancer. Cell Signal. 2018;51:99\u2013109. https:\/\/doi.org\/10.1016\/j.cellsig.2018.07.010 .","journal-title":"Cell Signal"},{"issue":"2","key":"1270_CR84","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1111\/ced.12022","volume":"38","author":"H Kanemura","year":"2013","unstructured":"Kanemura H, Fukushima S, Yamashita J, Jinnin M, Sakai K, Masuguchi S, et al. Serum epidermal growth factor receptor levels in patients with malignant melanoma. Clin Exp Dermatol. 2013;38(2):172\u20137. https:\/\/doi.org\/10.1111\/ced.12022 .","journal-title":"Clin Exp Dermatol"},{"key":"1270_CR85","doi-asserted-by":"publisher","DOI":"10.1097\/cmr.0000000000000488","author":"I Kenessey","year":"2018","unstructured":"Kenessey I, Kramer Z, Istvan L, Cserepes MT, Garay T, Hegedus B, et al. Inhibition of epidermal growth factor receptor improves antitumor efficacy of vemurafenib in BRAF-mutant human melanoma in preclinical model. Melanoma Res. 2018. https:\/\/doi.org\/10.1097\/cmr.0000000000000488 .","journal-title":"Melanoma Res"},{"issue":"20","key":"1270_CR86","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1042\/cs20160273","volume":"130","author":"M Takahashi","year":"2016","unstructured":"Takahashi M, Hasegawa Y, Gao C, Kuroki Y, Taniguchi N. N-glycans of growth factor receptors: their role in receptor function and disease implications. Clin Sci. 2016;130(20):1781\u201392. https:\/\/doi.org\/10.1042\/cs20160273 .","journal-title":"Clin Sci"},{"issue":"14","key":"1270_CR87","doi-asserted-by":"publisher","first-page":"4334","DOI":"10.1073\/pnas.1503262112","volume":"112","author":"K Kaszuba","year":"2015","unstructured":"Kaszuba K, Grzybek M, Orlowski A, Danne R, Rog T, Simons K, et al. N-Glycosylation as determinant of epidermal growth factor receptor conformation in membranes. Proc Natl Acad Sci USA. 2015;112(14):4334\u20139. https:\/\/doi.org\/10.1073\/pnas.1503262112 .","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"1270_CR88","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1002\/prot.25314","volume":"85","author":"M Azimzadeh Irani","year":"2017","unstructured":"Azimzadeh Irani M, Kannan S, Verma C. Role of N-glycosylation in EGFR ectodomain ligand binding. Proteins. 2017;85(8):1529\u201349. https:\/\/doi.org\/10.1002\/prot.25314 .","journal-title":"Proteins"},{"issue":"5","key":"1270_CR89","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1158\/0008-5472.can-06-3023","volume":"67","author":"S Yokoe","year":"2007","unstructured":"Yokoe S, Takahashi M, Asahi M, Lee SH, Li W, Osumi D, et al. The Asn418-linked N-glycan of ErbB3 plays a crucial role in preventing spontaneous heterodimerization and tumor promotion. Can Res. 2007;67(5):1935\u201342. https:\/\/doi.org\/10.1158\/0008-5472.can-06-3023 .","journal-title":"Can Res"},{"issue":"45","key":"1270_CR90","doi-asserted-by":"publisher","first-page":"14920","DOI":"10.1021\/bi050751j","volume":"44","author":"KB Whitson","year":"2005","unstructured":"Whitson KB, Whitson SR, Red-Brewer ML, McCoy AJ, Vitali AA, Walker F, et al. Functional effects of glycosylation at Asn-579 of the epidermal growth factor receptor. Biochemistry. 2005;44(45):14920\u201331. https:\/\/doi.org\/10.1021\/bi050751j .","journal-title":"Biochemistry"},{"issue":"28","key":"1270_CR91","doi-asserted-by":"publisher","first-page":"11332","DOI":"10.1073\/pnas.1107385108","volume":"108","author":"YC Liu","year":"2011","unstructured":"Liu YC, Yen HY, Chen CY, Chen CH, Cheng PF, Juan YH, et al. Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells. Proc Natl Acad Sci USA. 2011;108(28):11332\u20137. https:\/\/doi.org\/10.1073\/pnas.1107385108 .","journal-title":"Proc Natl Acad Sci USA"},{"issue":"22","key":"1270_CR92","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1073\/pnas.1507329112","volume":"112","author":"HY Yen","year":"2015","unstructured":"Yen HY, Liu YC, Chen NY, Tsai CF, Wang YT, Chen YJ, et al. Effect of sialylation on EGFR phosphorylation and resistance to tyrosine kinase inhibition. Proc Natl Acad Sci USA. 2015;112(22):6955\u201360. https:\/\/doi.org\/10.1073\/pnas.1507329112 .","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"1270_CR93","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13048-018-0385-0","volume":"11","author":"CM Britain","year":"2018","unstructured":"Britain CM, Holdbrooks AT, Anderson JC, Willey CD, Bellis SL. Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death. J Ovarian Res. 2018;11(1):12. https:\/\/doi.org\/10.1186\/s13048-018-0385-0 .","journal-title":"J Ovarian Res"},{"key":"1270_CR94","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2017.10.004","author":"M Singh","year":"2017","unstructured":"Singh M, Jadhav HR. Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors. Drug Discov Today. 2017. https:\/\/doi.org\/10.1016\/j.drudis.2017.10.004 .","journal-title":"Drug Discov Today"},{"issue":"1","key":"1270_CR95","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4103\/0971-5851.203502","volume":"38","author":"KS Udupa","year":"2017","unstructured":"Udupa KS, Rajendranath R, Sagar T, Thomas J. Differential toxicities of tyrosine kinase inhibitors in the management of metastatic lung cancer. Indian J Med Paediatr Oncol. 2017;38(1):15\u20137. https:\/\/doi.org\/10.4103\/0971-5851.203502 .","journal-title":"Indian J Med Paediatr Oncol"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-019-1270-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-019-1270-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-019-1270-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T01:44:45Z","timestamp":1663379085000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-019-1270-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,29]]},"references-count":95,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["1270"],"URL":"https:\/\/doi.org\/10.1007\/s12032-019-1270-4","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,29]]},"assertion":[{"value":"26 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"50"}}